Human Genome Epidemiology Literature Finder
Records 1 - 12 (of 12 Records) |
Query Trace: RRM2[original query] |
---|
Gemcitabine metabolic pathway genetic polymorphisms and response in patients with non-small cell lung cancer. Pharmacogenetics and genomics 2012 Feb 22 (2): 105-16. Li Liang, Schaid Daniel J, Fridley Brooke L, Kalari Krishna R, Jenkins Gregory D, Abo Ryan P, Batzler Anthony, Moon Irene, Pelleymounter Linda, Eckloff Bruce W, Wieben Eric D, Sun Zhifu, Yang Ping, Wang Liew |
RRM1 and RRM2 pharmacogenetics: association with phenotypes in HapMap cell lines and acute myeloid leukemia patients. Pharmacogenomics 2013 Sep 14 (12): 1449-66. Cao Xueyuan, Mitra Amit K, Pounds Stanley, Crews Kristine R, Gandhi Varsha, Plunkett William, Dolan M Eileen, Hartford Christine, Raimondi Susana, Campana Dario, Downing James, Rubnitz Jeffrey E, Ribeiro Raul C, Lamba Jatinder |
A 12-gene set predicts survival benefits from adjuvant chemotherapy in non-small cell lung cancer patients. Clinical cancer research : an official journal of the American Association for Cancer Research 2013 Jan . Tang H, Xiao G, Behrens C, Schiller J, Allen J, Chow CW, Suraokar M, Corvalan A, Mao JH, White M, Wistuba II, Minna JD, Xie Y |
RRM1, RRM2 and ERCC2 Gene Polymorphisms in Coronary Artery Disease. In vivo (Athens, Greece) 0 30 (5): 611-5. Altinkilic Emre Murat, Isbir Selim, Gormus Uzay, Yilmaz Seda Gulec, Dalan Altay Burak, Duman Selvi, Isbir Turg |
Investigation of some DNA repair genes association in non small cell lung cancer. Cellular and molecular biology (Noisy-le-Grand, France) 2015 61 (8): 57-62. Coskunpinar E, Yildiz P, Aynaci E, Turna A, Musteri Oltulu Y, Hekimoglu E, Isbir T, Yaylim |
An exploratory study of host polymorphisms in genes that clinically characterize breast cancer tumors and pretreatment cognitive performance in breast cancer survivors. Breast cancer (Dove Medical Press) 2017 9 95-110. Koleck Theresa A, Bender Catherine M, Clark Beth Z, Ryan Christopher M, Ghotkar Puja, Brufsky Adam, McAuliffe Priscilla F, Rastogi Priya, Sereika Susan M, Conley Yvette |
miR-211 regulates the expression of RRM2 in tumoral metastasis and recurrence in colorectal cancer patients with a k-ras gene mutation. Oncology letters 2018 May 15 (5): 8107-8117. Chang Chiu-Chun, Lin Chun-Che, Wang Chia-Hung, Huang Chi-Chou, Ke Tao-Wei, Wei Po-Li, Yeh Ken-Tu, Hsu Kai-Cheng, Hsu Nan-Yung, Cheng Ya-W |
Association of genetic polymorphisms in genes involved in Ara-C and dNTP metabolism pathway with chemosensitivity and prognosis of adult acute myeloid leukemia (AML). Journal of translational medicine 2018 Apr 16 (1): 90. Zhu Ke-Wei, Chen Peng, Zhang Dao-Yu, Yan Han, Liu Han, Cen Li-Na, Liu Yan-Ling, Cao Shan, Zhou Gan, Zeng Hui, Chen Shu-Ping, Zhao Xie-Lan, Chen Xiao-Pi |
Development and Validation of a Metabolic-related Prognostic Model for Hepatocellular Carcinoma. Journal of clinical and translational hepatology 2021 Apr 9 (2): 169-179. Huo Junyu, Wu Liqun, Zang Yunj |
Liquid Biopsy as a Diagnostic and Prognostic Tool for Women and Female Dogs with Breast Cancer. Cancers 2021 Oct 13 (20): . Colombo Jucimara, Moschetta-Pinheiro Marina Gobbe, Novais Adriana Alonso, Stoppe Bruna Ribeiro, Bonini Enrico Dumbra, Gonçalves Francine Moraes, Fukumasu Heidge, Coutinho Luiz Lehmann, Chuffa Luiz Gustavo de Almeida, Zuccari Debora Aparecida Pires de Camp |
A pan-cancer analysis of the oncogenic role of ribonucleotide reductase subunit M2 in human tumors. PeerJ 2022 12 10 e14432. Li Yaqun, Fu Wenhuan, Geng Zikai, Song Yun, Yang Xionggang, He Tianye, Wu Jian, Wang B |
A novel signature of combing cuproptosis- with ferroptosis-related genes for prediction of prognosis, immunologic therapy responses and drug sensitivity in hepatocellular carcinoma. Frontiers in oncology 2022 12 1000993. Zhao Chuanbing, Zhang Zhengle, Jing T |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 16, 2024
- Content source: